Feedback / Questions
TXR-1002 - Aria Pharma
https://www.prnewswire.com/news-releases/aria-pharmaceuticals-presents-positive-in-vivo-data-on-lead-idiopathic-pulmonary-fibrosis-treatment-candidate-301676824.html
Nov 14, 2022
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next